APO Research
Talk to an analyst

APO RESEARCH · REPORT

Site-directed Mutagenesis Service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Site-directed Mutagenesis Service Industry Growth and Trends Forecast to 2032

12 August 2026124 pages

Choose your research edition.

Industry ResearchSite-directed Mutagenesis Service Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Site-directed Mutagenesis Service Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Site-directed Mutagenesis Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Site-directed Mutagenesis Service Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Site-directed Mutagenesis Service Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

According to APO Research, the global Site-directed Mutagenesis Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Site-directed Mutagenesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Site-directed Mutagenesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Site-directed Mutagenesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Site-directed Mutagenesis Service market include Azenta Life Sciences, Thermo Fisher Scientific, Bon Opus Biosciences, Charles Rive, Creative Biogene, Synbio Technologies, Creative Biolabs, NovoPro and Bionexus, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Site-directed Mutagenesis Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Site-directed Mutagenesis Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Site-directed Mutagenesis Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Site-directed Mutagenesis Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Site-directed Mutagenesis Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Site-directed Mutagenesis Service Market by Company

Azenta Life Sciences

Thermo Fisher Scientific

Bon Opus Biosciences

Charles Rive

Creative Biogene

Synbio Technologies

Creative Biolabs

NovoPro

Bionexus

Biotech Desk

NorClone

Eton Bioscience

Syd Labs

Genosphere Biotechnologies

WZ Biosciences

FulenGen

GENEWIZ

iGene Biotechnology

Tsingke

AtaGenix

Zoonbio Biotechnology

GenScript

Eurofins

Applied Biological Materials

Site-directed Mutagenesis Service Segment by Type

Standard Site-directed Mutagenesis Service

Customized Site-directed Mutagenesis Service

Site-directed Mutagenesis Service Segment by Application

Scientific Research

Gene Therapy

Cell Therapy

Others

Site-directed Mutagenesis Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Site-directed Mutagenesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Site-directed Mutagenesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Site-directed Mutagenesis Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Site-directed Mutagenesis Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Site-directed Mutagenesis Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Site-directed Mutagenesis Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Site-directed Mutagenesis Service Market Share by Region (2021-2026) Table 4. Global Site-directed Mutagenesis Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Site-directed Mutagenesis Service Market Share by Region (2027-2032) Table 6. Global Site-directed Mutagenesis Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Site-directed Mutagenesis Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Site-directed Mutagenesis Service Market Size Share by Type (2021-2026) Table 9. Global Site-directed Mutagenesis Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Site-directed Mutagenesis Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America Site-directed Mutagenesis Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Site-directed Mutagenesis Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Site-directed Mutagenesis Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Site-directed Mutagenesis Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Site-directed Mutagenesis Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Site-directed Mutagenesis Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Site-directed Mutagenesis Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Site-directed Mutagenesis Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Site-directed Mutagenesis Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Site-directed Mutagenesis Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Site-directed Mutagenesis Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Site-directed Mutagenesis Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Site-directed Mutagenesis Service Market Size Share by Application (2021-2026) Table 24. Global Site-directed Mutagenesis Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Site-directed Mutagenesis Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America Site-directed Mutagenesis Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Site-directed Mutagenesis Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Site-directed Mutagenesis Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Site-directed Mutagenesis Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Site-directed Mutagenesis Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Site-directed Mutagenesis Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Site-directed Mutagenesis Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Site-directed Mutagenesis Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Site-directed Mutagenesis Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Site-directed Mutagenesis Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Site-directed Mutagenesis Service Industry Trends Table 37. Site-directed Mutagenesis Service Industry Drivers Table 38. Site-directed Mutagenesis Service Industry Opportunities and Challenges Table 39. Site-directed Mutagenesis Service Industry Restraints Table 40. Global Site-directed Mutagenesis Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Site-directed Mutagenesis Service Revenue Market Share by Company (2021-2026) Table 42. Global Site-directed Mutagenesis Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Site-directed Mutagenesis Service Key Company Headquarters & Area Served Table 44. Global Site-directed Mutagenesis Service Company, Product Type & Application Table 45. Global Site-directed Mutagenesis Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Site-directed Mutagenesis Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Azenta Life Sciences Company Information Table 49. Azenta Life Sciences Business Overview Table 50. Azenta Life Sciences Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Azenta Life Sciences Site-directed Mutagenesis Service Product Portfolio Table 52. Azenta Life Sciences Recent Development Table 53. Thermo Fisher Scientific Company Information Table 54. Thermo Fisher Scientific Business Overview Table 55. Thermo Fisher Scientific Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Thermo Fisher Scientific Site-directed Mutagenesis Service Product Portfolio Table 57. Thermo Fisher Scientific Recent Development Table 58. Bon Opus Biosciences Company Information Table 59. Bon Opus Biosciences Business Overview Table 60. Bon Opus Biosciences Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Bon Opus Biosciences Site-directed Mutagenesis Service Product Portfolio Table 62. Bon Opus Biosciences Recent Development Table 63. Charles Rive Company Information Table 64. Charles Rive Business Overview Table 65. Charles Rive Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Charles Rive Site-directed Mutagenesis Service Product Portfolio Table 67. Charles Rive Recent Development Table 68. Creative Biogene Company Information Table 69. Creative Biogene Business Overview Table 70. Creative Biogene Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Creative Biogene Site-directed Mutagenesis Service Product Portfolio Table 72. Creative Biogene Recent Development Table 73. Synbio Technologies Company Information Table 74. Synbio Technologies Business Overview Table 75. Synbio Technologies Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Synbio Technologies Site-directed Mutagenesis Service Product Portfolio Table 77. Synbio Technologies Recent Development Table 78. Creative Biolabs Company Information Table 79. Creative Biolabs Business Overview Table 80. Creative Biolabs Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Creative Biolabs Site-directed Mutagenesis Service Product Portfolio Table 82. Creative Biolabs Recent Development Table 83. NovoPro Company Information Table 84. NovoPro Business Overview Table 85. NovoPro Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. NovoPro Site-directed Mutagenesis Service Product Portfolio Table 87. NovoPro Recent Development Table 88. Bionexus Company Information Table 89. Bionexus Business Overview Table 90. Bionexus Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Bionexus Site-directed Mutagenesis Service Product Portfolio Table 92. Bionexus Recent Development Table 93. Biotech Desk Company Information Table 94. Biotech Desk Business Overview Table 95. Biotech Desk Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Biotech Desk Site-directed Mutagenesis Service Product Portfolio Table 97. Biotech Desk Recent Development Table 98. NorClone Company Information Table 99. NorClone Business Overview Table 100. NorClone Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. NorClone Site-directed Mutagenesis Service Product Portfolio Table 102. NorClone Recent Development Table 103. Eton Bioscience Company Information Table 104. Eton Bioscience Business Overview Table 105. Eton Bioscience Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Eton Bioscience Site-directed Mutagenesis Service Product Portfolio Table 107. Eton Bioscience Recent Development Table 108. Syd Labs Company Information Table 109. Syd Labs Business Overview Table 110. Syd Labs Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Syd Labs Site-directed Mutagenesis Service Product Portfolio Table 112. Syd Labs Recent Development Table 113. Genosphere Biotechnologies Company Information Table 114. Genosphere Biotechnologies Business Overview Table 115. Genosphere Biotechnologies Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Genosphere Biotechnologies Site-directed Mutagenesis Service Product Portfolio Table 117. Genosphere Biotechnologies Recent Development Table 118. WZ Biosciences Company Information Table 119. WZ Biosciences Business Overview Table 120. WZ Biosciences Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. WZ Biosciences Site-directed Mutagenesis Service Product Portfolio Table 122. WZ Biosciences Recent Development Table 123. FulenGen Company Information Table 124. FulenGen Business Overview Table 125. FulenGen Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. FulenGen Site-directed Mutagenesis Service Product Portfolio Table 127. FulenGen Recent Development Table 128. GENEWIZ Company Information Table 129. GENEWIZ Business Overview Table 130. GENEWIZ Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. GENEWIZ Site-directed Mutagenesis Service Product Portfolio Table 132. GENEWIZ Recent Development Table 133. iGene Biotechnology Company Information Table 134. iGene Biotechnology Business Overview Table 135. iGene Biotechnology Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. iGene Biotechnology Site-directed Mutagenesis Service Product Portfolio Table 137. iGene Biotechnology Recent Development Table 138. Tsingke Company Information Table 139. Tsingke Business Overview Table 140. Tsingke Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Tsingke Site-directed Mutagenesis Service Product Portfolio Table 142. Tsingke Recent Development Table 143. AtaGenix Company Information Table 144. AtaGenix Business Overview Table 145. AtaGenix Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. AtaGenix Site-directed Mutagenesis Service Product Portfolio Table 147. AtaGenix Recent Development Table 148. Zoonbio Biotechnology Company Information Table 149. Zoonbio Biotechnology Business Overview Table 150. Zoonbio Biotechnology Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Zoonbio Biotechnology Site-directed Mutagenesis Service Product Portfolio Table 152. Zoonbio Biotechnology Recent Development Table 153. GenScript Company Information Table 154. GenScript Business Overview Table 155. GenScript Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. GenScript Site-directed Mutagenesis Service Product Portfolio Table 157. GenScript Recent Development Table 158. Eurofins Company Information Table 159. Eurofins Business Overview Table 160. Eurofins Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Eurofins Site-directed Mutagenesis Service Product Portfolio Table 162. Eurofins Recent Development Table 163. Applied Biological Materials Company Information Table 164. Applied Biological Materials Business Overview Table 165. Applied Biological Materials Site-directed Mutagenesis Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. Applied Biological Materials Site-directed Mutagenesis Service Product Portfolio Table 167. Applied Biological Materials Recent Development Table 168. North America Site-directed Mutagenesis Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. North America Site-directed Mutagenesis Service Market Size by Country (2021-2026) & (US$ Million) Table 170. North America Site-directed Mutagenesis Service Market Share by Country (2021-2026) Table 171. North America Site-directed Mutagenesis Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. North America Site-directed Mutagenesis Service Market Share Forecast by Country (2027-2032) Table 173. Europe Site-directed Mutagenesis Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Europe Site-directed Mutagenesis Service Market Size by Country (2021-2026) & (US$ Million) Table 175. Europe Site-directed Mutagenesis Service Market Share by Country (2021-2026) Table 176. Europe Site-directed Mutagenesis Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Europe Site-directed Mutagenesis Service Market Share Forecast by Country (2027-2032) Table 178. Asia-Pacific Site-directed Mutagenesis Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Asia-Pacific Site-directed Mutagenesis Service Market Size by Country (2021-2026) & (US$ Million) Table 180. Asia-Pacific Site-directed Mutagenesis Service Market Share by Country (2021-2026) Table 181. Asia-Pacific Site-directed Mutagenesis Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Asia-Pacific Site-directed Mutagenesis Service Market Share Forecast by Country (2027-2032) Table 183. Latin America Site-directed Mutagenesis Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Latin America Site-directed Mutagenesis Service Market Size by Country (2021-2026) & (US$ Million) Table 185. Latin America Site-directed Mutagenesis Service Market Share by Country (2021-2026) Table 186. Latin America Site-directed Mutagenesis Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Latin America Site-directed Mutagenesis Service Market Share Forecast by Country (2027-2032) Table 188. Middle East & Africa Site-directed Mutagenesis Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Middle East & Africa Site-directed Mutagenesis Service Market Size by Country (2021-2026) & (US$ Million) Table 190. Middle East & Africa Site-directed Mutagenesis Service Market Share by Country (2021-2026) Table 191. Middle East & Africa Site-directed Mutagenesis Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Middle East & Africa Site-directed Mutagenesis Service Market Share Forecast by Country (2027-2032) Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Site-directed Mutagenesis Service Product Image Figure 3. Global Site-directed Mutagenesis Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Site-directed Mutagenesis Service Market Size (2021-2032) & (US$ Million) Figure 5. Global Site-directed Mutagenesis Service Market Share by Region: 2025 VS 2032 Figure 6. Global Site-directed Mutagenesis Service Market Share by Region (2021-2032) Figure 7. North America Site-directed Mutagenesis Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Site-directed Mutagenesis Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Site-directed Mutagenesis Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Site-directed Mutagenesis Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Site-directed Mutagenesis Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Standard Site-directed Mutagenesis Service Image Figure 13. Global Standard Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Customized Site-directed Mutagenesis Service Image Figure 15. Global Customized Site-directed Mutagenesis Service Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Site-directed Mutagenesis Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Site-directed Mutagenesis Service Market Share by Type 2025 VS 2032 Figure 18. North America Site-directed Mutagenesis Service Market Size Share by Type (2021-2032) Figure 19. Europe Site-directed Mutagenesis Service Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Site-directed Mutagenesis Service Market Size Share by Type (2021-2032) Figure 21. Latin America Site-directed Mutagenesis Service Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Site-directed Mutagenesis Service Market Size Share by Type (2021-2032) Figure 23. Scientific Research Image Figure 24. Global Scientific Research Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Gene Therapy Image Figure 26. Global Gene Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Cell Therapy Image Figure 28. Global Cell Therapy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Others Image Figure 30. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Site-directed Mutagenesis Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Site-directed Mutagenesis Service Market Share by Application 2025 VS 2032 Figure 33. North America Site-directed Mutagenesis Service Market Size Share by Application (2021-2032) Figure 34. Europe Site-directed Mutagenesis Service Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Site-directed Mutagenesis Service Market Size Share by Application (2021-2032) Figure 36. Latin America Site-directed Mutagenesis Service Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Site-directed Mutagenesis Service Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Site-directed Mutagenesis Service Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Site-directed Mutagenesis Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Site-directed Mutagenesis Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Site-directed Mutagenesis Service Market Share by Country (2021-2032) Figure 43. Europe Site-directed Mutagenesis Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Site-directed Mutagenesis Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Site-directed Mutagenesis Service Market Share by Country (2021-2032) Figure 46. Asia-Pacific Site-directed Mutagenesis Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Site-directed Mutagenesis Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Site-directed Mutagenesis Service Market Share by Country (2021-2032) Figure 49. Latin America Site-directed Mutagenesis Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Site-directed Mutagenesis Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Site-directed Mutagenesis Service Market Share by Country (2021-2032) Figure 52. Middle East & Africa Site-directed Mutagenesis Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Site-directed Mutagenesis Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Site-directed Mutagenesis Service Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Standard Site-directed Mutagenesis Service
  • Customized Site-directed Mutagenesis Service
Applications
  • Scientific Research
  • Gene Therapy
  • Cell Therapy
  • Others
Companies covered
  • Azenta Life Sciences
  • Thermo Fisher Scientific
  • Bon Opus Biosciences
  • Charles Rive
  • Creative Biogene
  • Synbio Technologies
  • Creative Biolabs
  • NovoPro
  • Bionexus
  • Biotech Desk
  • NorClone
  • Eton Bioscience
  • Syd Labs
  • Genosphere Biotechnologies
  • WZ Biosciences
  • FulenGen
  • GENEWIZ
  • iGene Biotechnology
  • Tsingke
  • AtaGenix
  • Zoonbio Biotechnology
  • GenScript
  • Eurofins
  • Applied Biological Materials

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Site-directed Mutagenesis Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Site-directed Mutagenesis Service Market Size by Region (2021-2032)
  5. 1.4.1 Global Site-directed Mutagenesis Service Market Size by Region (2021-2026)
  6. 1.4.2 Global Site-directed Mutagenesis Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions Site-directed Mutagenesis Service Market Size (2021-2032)
  8. 1.5.1 North America Site-directed Mutagenesis Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Site-directed Mutagenesis Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Site-directed Mutagenesis Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Site-directed Mutagenesis Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Site-directed Mutagenesis Service Market Size Growth Rate (2021-2032)
2 Site-directed Mutagenesis Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Standard Site-directed Mutagenesis Service
  3. 2.1.2 Customized Site-directed Mutagenesis Service
  4. 2.2 Global Site-directed Mutagenesis Service Market Size by Type
  5. 2.2.1 Global Site-directed Mutagenesis Service Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Site-directed Mutagenesis Service Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Site-directed Mutagenesis Service Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Site-directed Mutagenesis Service Market Size by Regions
  9. 2.3.1 North America Site-directed Mutagenesis Service Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Site-directed Mutagenesis Service Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Site-directed Mutagenesis Service Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Site-directed Mutagenesis Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Site-directed Mutagenesis Service Market Size Breakdown by Type (2021-2026)
3 Site-directed Mutagenesis Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Scientific Research
  3. 3.1.2 Gene Therapy
  4. 3.1.3 Cell Therapy
  5. 3.1.4 Others
  6. 3.2 Global Site-directed Mutagenesis Service Market Size by Application
  7. 3.2.1 Global Site-directed Mutagenesis Service Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Site-directed Mutagenesis Service Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Site-directed Mutagenesis Service Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Site-directed Mutagenesis Service Market Size by Regions
  11. 3.3.1 North America Site-directed Mutagenesis Service Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Site-directed Mutagenesis Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Site-directed Mutagenesis Service Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Site-directed Mutagenesis Service Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Site-directed Mutagenesis Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Site-directed Mutagenesis Service Industry Trends
  2. 4.2 Site-directed Mutagenesis Service Industry Drivers
  3. 4.3 Site-directed Mutagenesis Service Industry Opportunities and Challenges
  4. 4.4 Site-directed Mutagenesis Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Site-directed Mutagenesis Service Revenue (2021-2026)
  2. 5.2 Global Site-directed Mutagenesis Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Site-directed Mutagenesis Service Key Company Headquarters & Area Served
  4. 5.4 Global Site-directed Mutagenesis Service Company, Product Type & Application
  5. 5.5 Global Site-directed Mutagenesis Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Site-directed Mutagenesis Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Site-directed Mutagenesis Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Site-directed Mutagenesis Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Azenta Life Sciences
  2. 6.1.1 Azenta Life Sciences Company Information
  3. 6.1.2 Azenta Life Sciences Business Overview
  4. 6.1.3 Azenta Life Sciences Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Azenta Life Sciences Site-directed Mutagenesis Service Product Portfolio
  6. 6.1.5 Azenta Life Sciences Recent Developments
  7. 6.2 Thermo Fisher Scientific
  8. 6.2.1 Thermo Fisher Scientific Company Information
  9. 6.2.2 Thermo Fisher Scientific Business Overview
  10. 6.2.3 Thermo Fisher Scientific Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Thermo Fisher Scientific Site-directed Mutagenesis Service Product Portfolio
  12. 6.2.5 Thermo Fisher Scientific Recent Developments
  13. 6.3 Bon Opus Biosciences
  14. 6.3.1 Bon Opus Biosciences Company Information
  15. 6.3.2 Bon Opus Biosciences Business Overview
  16. 6.3.3 Bon Opus Biosciences Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Bon Opus Biosciences Site-directed Mutagenesis Service Product Portfolio
  18. 6.3.5 Bon Opus Biosciences Recent Developments
  19. 6.4 Charles Rive
  20. 6.4.1 Charles Rive Company Information
  21. 6.4.2 Charles Rive Business Overview
  22. 6.4.3 Charles Rive Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Charles Rive Site-directed Mutagenesis Service Product Portfolio
  24. 6.4.5 Charles Rive Recent Developments
  25. 6.5 Creative Biogene
  26. 6.5.1 Creative Biogene Company Information
  27. 6.5.2 Creative Biogene Business Overview
  28. 6.5.3 Creative Biogene Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Creative Biogene Site-directed Mutagenesis Service Product Portfolio
  30. 6.5.5 Creative Biogene Recent Developments
  31. 6.6 Synbio Technologies
  32. 6.6.1 Synbio Technologies Company Information
  33. 6.6.2 Synbio Technologies Business Overview
  34. 6.6.3 Synbio Technologies Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Synbio Technologies Site-directed Mutagenesis Service Product Portfolio
  36. 6.6.5 Synbio Technologies Recent Developments
  37. 6.7 Creative Biolabs
  38. 6.7.1 Creative Biolabs Company Information
  39. 6.7.2 Creative Biolabs Business Overview
  40. 6.7.3 Creative Biolabs Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Creative Biolabs Site-directed Mutagenesis Service Product Portfolio
  42. 6.7.5 Creative Biolabs Recent Developments
  43. 6.8 NovoPro
  44. 6.8.1 NovoPro Company Information
  45. 6.8.2 NovoPro Business Overview
  46. 6.8.3 NovoPro Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 NovoPro Site-directed Mutagenesis Service Product Portfolio
  48. 6.8.5 NovoPro Recent Developments
  49. 6.9 Bionexus
  50. 6.9.1 Bionexus Company Information
  51. 6.9.2 Bionexus Business Overview
  52. 6.9.3 Bionexus Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Bionexus Site-directed Mutagenesis Service Product Portfolio
  54. 6.9.5 Bionexus Recent Developments
  55. 6.10 Biotech Desk
  56. 6.10.1 Biotech Desk Company Information
  57. 6.10.2 Biotech Desk Business Overview
  58. 6.10.3 Biotech Desk Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Biotech Desk Site-directed Mutagenesis Service Product Portfolio
  60. 6.10.5 Biotech Desk Recent Developments
  61. 6.11 NorClone
  62. 6.11.1 NorClone Company Information
  63. 6.11.2 NorClone Business Overview
  64. 6.11.3 NorClone Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 NorClone Site-directed Mutagenesis Service Product Portfolio
  66. 6.11.5 NorClone Recent Developments
  67. 6.12 Eton Bioscience
  68. 6.12.1 Eton Bioscience Company Information
  69. 6.12.2 Eton Bioscience Business Overview
  70. 6.12.3 Eton Bioscience Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Eton Bioscience Site-directed Mutagenesis Service Product Portfolio
  72. 6.12.5 Eton Bioscience Recent Developments
  73. 6.13 Syd Labs
  74. 6.13.1 Syd Labs Company Information
  75. 6.13.2 Syd Labs Business Overview
  76. 6.13.3 Syd Labs Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Syd Labs Site-directed Mutagenesis Service Product Portfolio
  78. 6.13.5 Syd Labs Recent Developments
  79. 6.14 Genosphere Biotechnologies
  80. 6.14.1 Genosphere Biotechnologies Company Information
  81. 6.14.2 Genosphere Biotechnologies Business Overview
  82. 6.14.3 Genosphere Biotechnologies Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Genosphere Biotechnologies Site-directed Mutagenesis Service Product Portfolio
  84. 6.14.5 Genosphere Biotechnologies Recent Developments
  85. 6.15 WZ Biosciences
  86. 6.15.1 WZ Biosciences Company Information
  87. 6.15.2 WZ Biosciences Business Overview
  88. 6.15.3 WZ Biosciences Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 WZ Biosciences Site-directed Mutagenesis Service Product Portfolio
  90. 6.15.5 WZ Biosciences Recent Developments
  91. 6.16 FulenGen
  92. 6.16.1 FulenGen Company Information
  93. 6.16.2 FulenGen Business Overview
  94. 6.16.3 FulenGen Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 FulenGen Site-directed Mutagenesis Service Product Portfolio
  96. 6.16.5 FulenGen Recent Developments
  97. 6.17 GENEWIZ
  98. 6.17.1 GENEWIZ Company Information
  99. 6.17.2 GENEWIZ Business Overview
  100. 6.17.3 GENEWIZ Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 GENEWIZ Site-directed Mutagenesis Service Product Portfolio
  102. 6.17.5 GENEWIZ Recent Developments
  103. 6.18 iGene Biotechnology
  104. 6.18.1 iGene Biotechnology Company Information
  105. 6.18.2 iGene Biotechnology Business Overview
  106. 6.18.3 iGene Biotechnology Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 iGene Biotechnology Site-directed Mutagenesis Service Product Portfolio
  108. 6.18.5 iGene Biotechnology Recent Developments
  109. 6.19 Tsingke
  110. 6.19.1 Tsingke Company Information
  111. 6.19.2 Tsingke Business Overview
  112. 6.19.3 Tsingke Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Tsingke Site-directed Mutagenesis Service Product Portfolio
  114. 6.19.5 Tsingke Recent Developments
  115. 6.20 AtaGenix
  116. 6.20.1 AtaGenix Company Information
  117. 6.20.2 AtaGenix Business Overview
  118. 6.20.3 AtaGenix Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 AtaGenix Site-directed Mutagenesis Service Product Portfolio
  120. 6.20.5 AtaGenix Recent Developments
  121. 6.21 Zoonbio Biotechnology
  122. 6.21.1 Zoonbio Biotechnology Company Information
  123. 6.21.2 Zoonbio Biotechnology Business Overview
  124. 6.21.3 Zoonbio Biotechnology Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Zoonbio Biotechnology Site-directed Mutagenesis Service Product Portfolio
  126. 6.21.5 Zoonbio Biotechnology Recent Developments
  127. 6.22 GenScript
  128. 6.22.1 GenScript Company Information
  129. 6.22.2 GenScript Business Overview
  130. 6.22.3 GenScript Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 GenScript Site-directed Mutagenesis Service Product Portfolio
  132. 6.22.5 GenScript Recent Developments
  133. 6.23 Eurofins
  134. 6.23.1 Eurofins Company Information
  135. 6.23.2 Eurofins Business Overview
  136. 6.23.3 Eurofins Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Eurofins Site-directed Mutagenesis Service Product Portfolio
  138. 6.23.5 Eurofins Recent Developments
  139. 6.24 Applied Biological Materials
  140. 6.24.1 Applied Biological Materials Company Information
  141. 6.24.2 Applied Biological Materials Business Overview
  142. 6.24.3 Applied Biological Materials Site-directed Mutagenesis Service Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 Applied Biological Materials Site-directed Mutagenesis Service Product Portfolio
  144. 6.24.5 Applied Biological Materials Recent Developments
7 North America
  1. 7.1 North America Site-directed Mutagenesis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Site-directed Mutagenesis Service Market Size by Country (2021-2026)
  3. 7.3 North America Site-directed Mutagenesis Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Site-directed Mutagenesis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Site-directed Mutagenesis Service Market Size by Country (2021-2026)
  3. 8.3 Europe Site-directed Mutagenesis Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Site-directed Mutagenesis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Site-directed Mutagenesis Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Site-directed Mutagenesis Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Site-directed Mutagenesis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Site-directed Mutagenesis Service Market Size by Country (2021-2026)
  3. 10.3 South America Site-directed Mutagenesis Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Site-directed Mutagenesis Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Site-directed Mutagenesis Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Site-directed Mutagenesis Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst